F086 Alopecia Areata: New Therapies
DESCRIPTION
With the current interest in hair loss conditions being on the rise, it is important to understand alopecia areata as it is the most common cause of immune- mediated alopecia, affecting 2% of the USA population. The intricate pathology, patients demographics and comorbidities, and the new therapeutic options will be discussed. The team of speakers have been leaders in developing alopecia areata severity scale and therapeutic guidelines.
LEARNING OBJECTIVES
Compare and analyze novel therapies for alopecia areata
Identify patients who are eligible for novel medications considering their comorbidities
Describe therapeutic guidelines for alopecia areata, including dosing, duration of treatment and clinical prognosis
SCHEDULE
1:00 PM
Bald Spots & Plot Twists: The Real Clues to Diagnosing Alopecia Areata
Chesahna Kindred, MD, MBA, FAAD
1:15 PM
Alopecia Areata: Health Risks, Comorbidities, and Survival
Rodrigo Pirmez, MD
1:30 PM
Alopecia Areata as an Autoimmune Spectrum Disorder: Lessons from Dermatology–Rheumatology Interfaces
Michelle Min, MD, MSc, FAAD
1:45 PM
The success of JAK inhibitors in AA
Brett King, MD, PhD, FAAD
2:00 PM
Cytokine Crossroads: Linking Atopic Disease and Alopecia Areata
Emma Guttman, MD, PhD, FAAD
2:15 PM
Minoxidil: what you need to know!
Paulo Müller Ramos, MD, IFAAD
2:30 PM
Little Patients, Big Impact: What to Do for Children with Alopecia Areata
Maria Gnarra Buethe, MD, PhD, FAAD
2:45 PM
Excitement about Novel AA Therapies
Ali Jabbari, MD, PhD, FAAD
DIRECTOR
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
SPEAKERS
Maria Gnarra Buethe, MD, PhD, FAAD
Emma Guttman, MD, PhD, FAAD
Ali Jabbari, MD, PhD, FAAD
Chesahna Kindred, MD, MBA, FAAD
Brett King, MD, PhD, FAAD
Michelle Min, MD, MSc, FAAD
Paulo Müller Ramos, MD, IFAAD
Rodrigo Pirmez, MD
DISCLOSURES
Maria Gnarra Buethe, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Emma Guttman, MD, PhD, FAAD
AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Fees); Biolojic Design – Consultant (1099 relationship)(Fees); Bionyra Pharma – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celldex – Consultant (1099 relationship)(Fees); Cue Biopharma – Consultant (1099 relationship)(Fees); CytoReason – Consultant (1099 relationship)(Fees); DBV Technologies – Consultant (1099 relationship)(Fees); Dualitas Therapeutics – Consultant (1099 relationship)(Fees); Electra Therapeutics – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Generate Biomedicines – Consultant (1099 relationship)(Fees); Gilead Sciences, Inc – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Infimmune – Consultant (1099 relationship)(Fees); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); Kymera Therapeutics – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Matchpoint Therapeutics – Consultant (1099 relationship)(Fees); Merck – Consultant(Fees), Consultant(Honoraria); Navigator Medicines – Consultant (1099 relationship)(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Opsidio – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Propeller Bio – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Consultant (1099 relationship)(Stock Options), Investigator(Grants/Research Funding); RayThera – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Rubedo Life Sciences – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees); Sitryx – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); TRex Bio – Consultant (1099 relationship)(Fees); Triveni Bio – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Ventyx Biosciences – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VRG Therapeutics – Consultant (1099 relationship)(Fees); Xencor – Consultant (1099 relationship)(Fees);
Ali Jabbari, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria); Almirall – Investigator(Grants/Research Funding); Department. of Veterans Affairs – Investigator(Grants/Research Funding); HCW Biologics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); National Institutes of Health – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UpToDate, Inc. – Independent Contractor(Other Financial Benefit);
Chesahna Kindred, MD, MBA, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Fees); Aerolase – Speaker(Fees); Arcutis Biotherapeutics – Speaker(Fees); Eli Lilly – Investigator(Fees); Factor Medical – Speaker(Fees); Lilly ICOS LLC – Advisory Board(Fees), Speaker/Faculty Education(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); UCB – Advisory Board(Fees); Xtresse – Stockholder Private Company(No Compensation Received);
Brett King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Michelle Min, MD, MSc, FAAD
Amgen – Investigator(Grants/Research Funding); AstraZeneca – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Other Financial Benefit), Investigator(Grants/Research Funding); McGraw-Hill Companies – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Investigator(Grants/Research Funding);
Paulo Müller Ramos, MD, IFAAD
Ache Laboratório Farmaceuticso S.A. – Advisory Board(Fees); Farmoquímica S.A. (FQM) – Speaker(Fees); L'Oreal – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); TheraSkin Farmacêutica – Speaker(Fees);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees); Vichy Laboratoires – Speaker(Fees);